文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

作者信息

Russell Clark D, Millar Jonathan E, Baillie J Kenneth

机构信息

University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute Edinburgh, Edinburgh, UK.

Genetics and Genomics, Roslin Institute, University of Edinburgh, Edinburgh EH25 9RG, UK.

出版信息

Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.

DOI:10.1016/S0140-6736(20)30317-2
PMID:32043983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7134694/
Abstract
摘要

相似文献

[1]
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

Lancet. 2020-2-15

[2]
[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].

Zhonghua Jie He He Hu Xi Za Zhi. 2020-3-12

[3]
What can we learn about corticosteroid therapy as a treatment for COVID-19?

Osteoporos Int. 2020-8

[4]
Dexamethasone in the management of covid -19.

BMJ. 2020-7-3

[5]
On the use of corticosteroids for 2019-nCoV pneumonia.

Lancet. 2020-2-29

[6]
Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia　- Something to Be Concerned About?

Circ J. 2020-9-25

[7]
[Glucocorticoid for coronavirus disease 2019: a dilemma].

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020-3

[8]
Therapeutic potential of ciclesonide inahalation for COVID-19 pneumonia: Report of three cases.

J Infect Chemother. 2020-4-16

[9]
COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.

Pharmacotherapy. 2020-5

[10]
Research Progress of Drug Treatment in Novel Coronavirus Pneumonia.

AAPS PharmSciTech. 2020-5-13

引用本文的文献

[1]
Drug utilisation patterns & clinical outcomes in hospitalised COVID-19 patients: A geospatial & machine learning approach.

Indian J Med Res. 2025-4

[2]
Dual threat: Susceptibility mechanisms and treatment strategies for COVID-19 and bacterial co-infections.

Comput Struct Biotechnol J. 2025-5-22

[3]
Feature Importance Analysis by Nowcasting Perspective to Predict COVID-19.

Mob Netw Appl. 2022

[4]
[Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology].

Rev Colomb Reumatol. 2020

[5]
Revisiting the role of steroidal therapeutics in the 21st century: an update on FDA approved steroidal drugs (2000-2024).

RSC Med Chem. 2025-5-8

[6]
The comparative effectiveness of methylprednisolone versus dexamethasone on in-hospital mortality in patients with severe or critical COVID-19: a retrospective observational study.

Ther Adv Infect Dis. 2025-4-22

[7]
B cells modulate lung antiviral inflammatory responses via the neurotransmitter acetylcholine.

Nat Immunol. 2025-5

[8]
Examining efficacy and safety of ethyl acetate extract from as complementary therapy in COVID-19: A randomized, multicenter, controlled clinical trial.

Avicenna J Phytomed. 2024

[9]
Deep insight into cytokine storm: from pathogenesis to treatment.

Signal Transduct Target Ther. 2025-4-16

[10]
Pharmacological validation of a novel exopolysaccharide from sp. 139 to effectively inhibit cytokine storms.

Heliyon. 2024-7-9

本文引用的文献

[1]
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Lancet. 2020-1-30

[2]
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Lancet. 2020-1-24

[3]
Pharmacological agents for adults with acute respiratory distress syndrome.

Cochrane Database Syst Rev. 2019-7-23

[4]
The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis.

Crit Care. 2019-3-27

[5]
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.

N Engl J Med. 2018-3-1

[6]
Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.

N Engl J Med. 2018-1-19

[7]
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome.

Am J Respir Crit Care Med. 2018-3-15

[8]
Middle East Respiratory Syndrome.

N Engl J Med. 2017-2-9

[9]
The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness.

Chest. 2011-5-12

[10]
Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status.

Crit Care Med. 2010-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索